nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—Cranial nerve paralysis—Paclitaxel—ovarian cancer	0.0933	0.095	CcSEcCtD
Mepivacaine—Convulsion—Altretamine—ovarian cancer	0.0224	0.0228	CcSEcCtD
Mepivacaine—Asthenia—Altretamine—ovarian cancer	0.0151	0.0154	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Topotecan—ovarian cancer	0.014	0.0143	CcSEcCtD
Mepivacaine—Dizziness—Altretamine—ovarian cancer	0.0139	0.0142	CcSEcCtD
Mepivacaine—Lidocaine—EGFR—ovarian cancer	0.0135	0.767	CrCbGaD
Mepivacaine—Vomiting—Altretamine—ovarian cancer	0.0134	0.0136	CcSEcCtD
Mepivacaine—Cardiac arrest—Topotecan—ovarian cancer	0.0129	0.0131	CcSEcCtD
Mepivacaine—Cardiac arrest—Melphalan—ovarian cancer	0.0126	0.0129	CcSEcCtD
Mepivacaine—Nausea—Altretamine—ovarian cancer	0.0125	0.0127	CcSEcCtD
Mepivacaine—Body temperature increased—Carboplatin—ovarian cancer	0.0115	0.0117	CcSEcCtD
Mepivacaine—Atrioventricular block—Paclitaxel—ovarian cancer	0.0111	0.0113	CcSEcCtD
Mepivacaine—Urinary incontinence—Paclitaxel—ovarian cancer	0.0104	0.0106	CcSEcCtD
Mepivacaine—Sweating—Topotecan—ovarian cancer	0.01	0.0102	CcSEcCtD
Mepivacaine—Paralysis—Epirubicin—ovarian cancer	0.00885	0.00901	CcSEcCtD
Mepivacaine—Swelling—Paclitaxel—ovarian cancer	0.00885	0.00901	CcSEcCtD
Mepivacaine—Tremor—Chlorambucil—ovarian cancer	0.0086	0.00876	CcSEcCtD
Mepivacaine—Agitation—Chlorambucil—ovarian cancer	0.00844	0.00859	CcSEcCtD
Mepivacaine—Chills—Topotecan—ovarian cancer	0.00842	0.00858	CcSEcCtD
Mepivacaine—Angioedema—Chlorambucil—ovarian cancer	0.00839	0.00854	CcSEcCtD
Mepivacaine—Ventricular arrhythmia—Epirubicin—ovarian cancer	0.00831	0.00846	CcSEcCtD
Mepivacaine—Paralysis—Doxorubicin—ovarian cancer	0.00819	0.00834	CcSEcCtD
Mepivacaine—Convulsion—Chlorambucil—ovarian cancer	0.00795	0.0081	CcSEcCtD
Mepivacaine—Back pain—Topotecan—ovarian cancer	0.00791	0.00805	CcSEcCtD
Mepivacaine—Ventricular arrhythmia—Doxorubicin—ovarian cancer	0.00769	0.00783	CcSEcCtD
Mepivacaine—Swelling—Docetaxel—ovarian cancer	0.0075	0.00764	CcSEcCtD
Mepivacaine—Angioedema—Topotecan—ovarian cancer	0.00747	0.0076	CcSEcCtD
Mepivacaine—Cardiac arrest—Paclitaxel—ovarian cancer	0.00743	0.00756	CcSEcCtD
Mepivacaine—Erythema—Vinorelbine—ovarian cancer	0.00699	0.00712	CcSEcCtD
Mepivacaine—Convulsion—Melphalan—ovarian cancer	0.00693	0.00706	CcSEcCtD
Mepivacaine—Back pain—Vinorelbine—ovarian cancer	0.00676	0.00688	CcSEcCtD
Mepivacaine—Anaphylactic shock—Topotecan—ovarian cancer	0.00667	0.00679	CcSEcCtD
Mepivacaine—Sweating increased—Paclitaxel—ovarian cancer	0.00657	0.00669	CcSEcCtD
Mepivacaine—Oedema—Melphalan—ovarian cancer	0.00653	0.00665	CcSEcCtD
Mepivacaine—Anaphylactic shock—Melphalan—ovarian cancer	0.00653	0.00665	CcSEcCtD
Mepivacaine—Hyperhidrosis—Topotecan—ovarian cancer	0.00645	0.00656	CcSEcCtD
Mepivacaine—Angioedema—Vinorelbine—ovarian cancer	0.00639	0.0065	CcSEcCtD
Mepivacaine—Tachycardia—Melphalan—ovarian cancer	0.00637	0.00649	CcSEcCtD
Mepivacaine—Atrioventricular block—Epirubicin—ovarian cancer	0.00634	0.00645	CcSEcCtD
Mepivacaine—Hypotension—Melphalan—ovarian cancer	0.0061	0.00621	CcSEcCtD
Mepivacaine—Hypertension—Vinorelbine—ovarian cancer	0.00604	0.00614	CcSEcCtD
Mepivacaine—Paraesthesia—Topotecan—ovarian cancer	0.00599	0.0061	CcSEcCtD
Mepivacaine—Urticaria—Chlorambucil—ovarian cancer	0.00595	0.00606	CcSEcCtD
Mepivacaine—Body temperature increased—Chlorambucil—ovarian cancer	0.00592	0.00603	CcSEcCtD
Mepivacaine—Atrioventricular block—Doxorubicin—ovarian cancer	0.00587	0.00597	CcSEcCtD
Mepivacaine—Paraesthesia—Melphalan—ovarian cancer	0.00586	0.00597	CcSEcCtD
Mepivacaine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00571	0.00581	CcSEcCtD
Mepivacaine—Tachycardia—Vinorelbine—ovarian cancer	0.00557	0.00567	CcSEcCtD
Mepivacaine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00552	0.00562	CcSEcCtD
Mepivacaine—Bradycardia—Paclitaxel—ovarian cancer	0.0055	0.0056	CcSEcCtD
Mepivacaine—Asthenia—Chlorambucil—ovarian cancer	0.00538	0.00547	CcSEcCtD
Mepivacaine—Hypotension—Vinorelbine—ovarian cancer	0.00533	0.00543	CcSEcCtD
Mepivacaine—Pruritus—Chlorambucil—ovarian cancer	0.0053	0.0054	CcSEcCtD
Mepivacaine—Urticaria—Topotecan—ovarian cancer	0.0053	0.00539	CcSEcCtD
Mepivacaine—Body temperature increased—Topotecan—ovarian cancer	0.00527	0.00537	CcSEcCtD
Mepivacaine—Urticaria—Melphalan—ovarian cancer	0.00519	0.00528	CcSEcCtD
Mepivacaine—Paraesthesia—Vinorelbine—ovarian cancer	0.00512	0.00522	CcSEcCtD
Mepivacaine—Tinnitus—Paclitaxel—ovarian cancer	0.00504	0.00513	CcSEcCtD
Mepivacaine—Hypersensitivity—Topotecan—ovarian cancer	0.00491	0.005	CcSEcCtD
Mepivacaine—Chills—Paclitaxel—ovarian cancer	0.00485	0.00493	CcSEcCtD
Mepivacaine—Hypersensitivity—Melphalan—ovarian cancer	0.00481	0.0049	CcSEcCtD
Mepivacaine—Asthenia—Topotecan—ovarian cancer	0.00479	0.00487	CcSEcCtD
Mepivacaine—Vomiting—Chlorambucil—ovarian cancer	0.00476	0.00485	CcSEcCtD
Mepivacaine—Pruritus—Topotecan—ovarian cancer	0.00472	0.0048	CcSEcCtD
Mepivacaine—Erythema—Paclitaxel—ovarian cancer	0.0047	0.00479	CcSEcCtD
Mepivacaine—Asthenia—Melphalan—ovarian cancer	0.00469	0.00477	CcSEcCtD
Mepivacaine—Pruritus—Melphalan—ovarian cancer	0.00462	0.0047	CcSEcCtD
Mepivacaine—Tension—Paclitaxel—ovarian cancer	0.00461	0.0047	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00461	0.0047	CcSEcCtD
Mepivacaine—Nervousness—Paclitaxel—ovarian cancer	0.00457	0.00465	CcSEcCtD
Mepivacaine—Back pain—Paclitaxel—ovarian cancer	0.00455	0.00463	CcSEcCtD
Mepivacaine—Urticaria—Vinorelbine—ovarian cancer	0.00453	0.00461	CcSEcCtD
Mepivacaine—Body temperature increased—Vinorelbine—ovarian cancer	0.00451	0.00459	CcSEcCtD
Mepivacaine—Nausea—Chlorambucil—ovarian cancer	0.00445	0.00453	CcSEcCtD
Mepivacaine—Vision blurred—Paclitaxel—ovarian cancer	0.00443	0.00451	CcSEcCtD
Mepivacaine—Dizziness—Topotecan—ovarian cancer	0.00441	0.00449	CcSEcCtD
Mepivacaine—Tremor—Paclitaxel—ovarian cancer	0.00441	0.00449	CcSEcCtD
Mepivacaine—Agitation—Paclitaxel—ovarian cancer	0.00432	0.0044	CcSEcCtD
Mepivacaine—Angioedema—Paclitaxel—ovarian cancer	0.0043	0.00437	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00427	0.00434	CcSEcCtD
Mepivacaine—Cardiac arrest—Epirubicin—ovarian cancer	0.00425	0.00432	CcSEcCtD
Mepivacaine—Vomiting—Topotecan—ovarian cancer	0.00424	0.00432	CcSEcCtD
Mepivacaine—Syncope—Paclitaxel—ovarian cancer	0.00422	0.00429	CcSEcCtD
Mepivacaine—Hypersensitivity—Vinorelbine—ovarian cancer	0.0042	0.00428	CcSEcCtD
Mepivacaine—Headache—Topotecan—ovarian cancer	0.00418	0.00425	CcSEcCtD
Mepivacaine—Vomiting—Melphalan—ovarian cancer	0.00415	0.00423	CcSEcCtD
Mepivacaine—Loss of consciousness—Paclitaxel—ovarian cancer	0.00413	0.00421	CcSEcCtD
Mepivacaine—Lidocaine—ABCB1—ovarian cancer	0.00412	0.233	CrCbGaD
Mepivacaine—Chills—Docetaxel—ovarian cancer	0.00411	0.00418	CcSEcCtD
Mepivacaine—Asthenia—Vinorelbine—ovarian cancer	0.00409	0.00417	CcSEcCtD
Mepivacaine—Convulsion—Paclitaxel—ovarian cancer	0.00407	0.00415	CcSEcCtD
Mepivacaine—Hypertension—Paclitaxel—ovarian cancer	0.00406	0.00413	CcSEcCtD
Mepivacaine—Pruritus—Vinorelbine—ovarian cancer	0.00404	0.00411	CcSEcCtD
Mepivacaine—Anxiety—Paclitaxel—ovarian cancer	0.00399	0.00406	CcSEcCtD
Mepivacaine—Erythema—Docetaxel—ovarian cancer	0.00399	0.00406	CcSEcCtD
Mepivacaine—Nausea—Topotecan—ovarian cancer	0.00396	0.00403	CcSEcCtD
Mepivacaine—Cardiac arrest—Doxorubicin—ovarian cancer	0.00393	0.004	CcSEcCtD
Mepivacaine—Nausea—Melphalan—ovarian cancer	0.00388	0.00395	CcSEcCtD
Mepivacaine—Back pain—Docetaxel—ovarian cancer	0.00386	0.00392	CcSEcCtD
Mepivacaine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00384	0.00391	CcSEcCtD
Mepivacaine—Oedema—Paclitaxel—ovarian cancer	0.00384	0.00391	CcSEcCtD
Mepivacaine—Shock—Paclitaxel—ovarian cancer	0.00378	0.00384	CcSEcCtD
Mepivacaine—Dizziness—Vinorelbine—ovarian cancer	0.00377	0.00384	CcSEcCtD
Mepivacaine—Tachycardia—Paclitaxel—ovarian cancer	0.00375	0.00381	CcSEcCtD
Mepivacaine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00371	0.00378	CcSEcCtD
Mepivacaine—Vomiting—Vinorelbine—ovarian cancer	0.00363	0.00369	CcSEcCtD
Mepivacaine—Hypotension—Paclitaxel—ovarian cancer	0.00359	0.00365	CcSEcCtD
Mepivacaine—Headache—Vinorelbine—ovarian cancer	0.00357	0.00364	CcSEcCtD
Mepivacaine—Syncope—Docetaxel—ovarian cancer	0.00357	0.00364	CcSEcCtD
Mepivacaine—Loss of consciousness—Docetaxel—ovarian cancer	0.0035	0.00357	CcSEcCtD
Mepivacaine—Convulsion—Docetaxel—ovarian cancer	0.00345	0.00352	CcSEcCtD
Mepivacaine—Paraesthesia—Paclitaxel—ovarian cancer	0.00345	0.00351	CcSEcCtD
Mepivacaine—Hypertension—Docetaxel—ovarian cancer	0.00344	0.0035	CcSEcCtD
Mepivacaine—Drowsiness—Epirubicin—ovarian cancer	0.00344	0.0035	CcSEcCtD
Mepivacaine—Somnolence—Paclitaxel—ovarian cancer	0.00341	0.00347	CcSEcCtD
Mepivacaine—Nausea—Vinorelbine—ovarian cancer	0.00339	0.00345	CcSEcCtD
Mepivacaine—Sweating—Epirubicin—ovarian cancer	0.0033	0.00336	CcSEcCtD
Mepivacaine—Anaphylactic shock—Docetaxel—ovarian cancer	0.00325	0.00331	CcSEcCtD
Mepivacaine—Oedema—Docetaxel—ovarian cancer	0.00325	0.00331	CcSEcCtD
Mepivacaine—Shock—Docetaxel—ovarian cancer	0.0032	0.00326	CcSEcCtD
Mepivacaine—Drowsiness—Doxorubicin—ovarian cancer	0.00318	0.00324	CcSEcCtD
Mepivacaine—Tachycardia—Docetaxel—ovarian cancer	0.00318	0.00323	CcSEcCtD
Mepivacaine—Bradycardia—Epirubicin—ovarian cancer	0.00314	0.0032	CcSEcCtD
Mepivacaine—Sweating—Doxorubicin—ovarian cancer	0.00305	0.00311	CcSEcCtD
Mepivacaine—Urticaria—Paclitaxel—ovarian cancer	0.00305	0.0031	CcSEcCtD
Mepivacaine—Hypotension—Docetaxel—ovarian cancer	0.00304	0.00309	CcSEcCtD
Mepivacaine—Body temperature increased—Paclitaxel—ovarian cancer	0.00303	0.00309	CcSEcCtD
Mepivacaine—Paraesthesia—Docetaxel—ovarian cancer	0.00292	0.00297	CcSEcCtD
Mepivacaine—Bradycardia—Doxorubicin—ovarian cancer	0.00291	0.00296	CcSEcCtD
Mepivacaine—Somnolence—Docetaxel—ovarian cancer	0.00289	0.00294	CcSEcCtD
Mepivacaine—Tinnitus—Epirubicin—ovarian cancer	0.00288	0.00293	CcSEcCtD
Mepivacaine—Hypersensitivity—Paclitaxel—ovarian cancer	0.00283	0.00288	CcSEcCtD
Mepivacaine—Chills—Epirubicin—ovarian cancer	0.00277	0.00282	CcSEcCtD
Mepivacaine—Asthenia—Paclitaxel—ovarian cancer	0.00275	0.0028	CcSEcCtD
Mepivacaine—Pruritus—Paclitaxel—ovarian cancer	0.00272	0.00276	CcSEcCtD
Mepivacaine—Erythema—Epirubicin—ovarian cancer	0.00269	0.00274	CcSEcCtD
Mepivacaine—Tinnitus—Doxorubicin—ovarian cancer	0.00266	0.00271	CcSEcCtD
Mepivacaine—Tension—Epirubicin—ovarian cancer	0.00264	0.00269	CcSEcCtD
Mepivacaine—Nervousness—Epirubicin—ovarian cancer	0.00261	0.00266	CcSEcCtD
Mepivacaine—Back pain—Epirubicin—ovarian cancer	0.0026	0.00265	CcSEcCtD
Mepivacaine—Body temperature increased—Docetaxel—ovarian cancer	0.00257	0.00262	CcSEcCtD
Mepivacaine—Chills—Doxorubicin—ovarian cancer	0.00256	0.00261	CcSEcCtD
Mepivacaine—Dizziness—Paclitaxel—ovarian cancer	0.00254	0.00258	CcSEcCtD
Mepivacaine—Vision blurred—Epirubicin—ovarian cancer	0.00253	0.00258	CcSEcCtD
Mepivacaine—Erythema—Doxorubicin—ovarian cancer	0.00249	0.00253	CcSEcCtD
Mepivacaine—Agitation—Epirubicin—ovarian cancer	0.00247	0.00252	CcSEcCtD
Mepivacaine—Tension—Doxorubicin—ovarian cancer	0.00244	0.00249	CcSEcCtD
Mepivacaine—Vomiting—Paclitaxel—ovarian cancer	0.00244	0.00248	CcSEcCtD
Mepivacaine—Nervousness—Doxorubicin—ovarian cancer	0.00242	0.00246	CcSEcCtD
Mepivacaine—Syncope—Epirubicin—ovarian cancer	0.00241	0.00245	CcSEcCtD
Mepivacaine—Back pain—Doxorubicin—ovarian cancer	0.00241	0.00245	CcSEcCtD
Mepivacaine—Headache—Paclitaxel—ovarian cancer	0.0024	0.00245	CcSEcCtD
Mepivacaine—Hypersensitivity—Docetaxel—ovarian cancer	0.0024	0.00244	CcSEcCtD
Mepivacaine—Loss of consciousness—Epirubicin—ovarian cancer	0.00236	0.00241	CcSEcCtD
Mepivacaine—Vision blurred—Doxorubicin—ovarian cancer	0.00234	0.00239	CcSEcCtD
Mepivacaine—Asthenia—Docetaxel—ovarian cancer	0.00233	0.00238	CcSEcCtD
Mepivacaine—Convulsion—Epirubicin—ovarian cancer	0.00233	0.00237	CcSEcCtD
Mepivacaine—Hypertension—Epirubicin—ovarian cancer	0.00232	0.00236	CcSEcCtD
Mepivacaine—Pruritus—Docetaxel—ovarian cancer	0.0023	0.00234	CcSEcCtD
Mepivacaine—Agitation—Doxorubicin—ovarian cancer	0.00229	0.00233	CcSEcCtD
Mepivacaine—Anxiety—Epirubicin—ovarian cancer	0.00228	0.00232	CcSEcCtD
Mepivacaine—Nausea—Paclitaxel—ovarian cancer	0.00228	0.00232	CcSEcCtD
Mepivacaine—Syncope—Doxorubicin—ovarian cancer	0.00223	0.00227	CcSEcCtD
Mepivacaine—Anaphylactic shock—Epirubicin—ovarian cancer	0.00219	0.00223	CcSEcCtD
Mepivacaine—Oedema—Epirubicin—ovarian cancer	0.00219	0.00223	CcSEcCtD
Mepivacaine—Loss of consciousness—Doxorubicin—ovarian cancer	0.00219	0.00223	CcSEcCtD
Mepivacaine—Shock—Epirubicin—ovarian cancer	0.00216	0.0022	CcSEcCtD
Mepivacaine—Convulsion—Doxorubicin—ovarian cancer	0.00216	0.00219	CcSEcCtD
Mepivacaine—Dizziness—Docetaxel—ovarian cancer	0.00215	0.00219	CcSEcCtD
Mepivacaine—Hypertension—Doxorubicin—ovarian cancer	0.00215	0.00219	CcSEcCtD
Mepivacaine—Tachycardia—Epirubicin—ovarian cancer	0.00214	0.00218	CcSEcCtD
Mepivacaine—Hyperhidrosis—Epirubicin—ovarian cancer	0.00212	0.00216	CcSEcCtD
Mepivacaine—Anxiety—Doxorubicin—ovarian cancer	0.00211	0.00215	CcSEcCtD
Mepivacaine—Vomiting—Docetaxel—ovarian cancer	0.00207	0.00211	CcSEcCtD
Mepivacaine—Hypotension—Epirubicin—ovarian cancer	0.00205	0.00209	CcSEcCtD
Mepivacaine—Headache—Docetaxel—ovarian cancer	0.00204	0.00207	CcSEcCtD
Mepivacaine—Oedema—Doxorubicin—ovarian cancer	0.00203	0.00207	CcSEcCtD
Mepivacaine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00203	0.00207	CcSEcCtD
Mepivacaine—Shock—Doxorubicin—ovarian cancer	0.002	0.00203	CcSEcCtD
Mepivacaine—Tachycardia—Doxorubicin—ovarian cancer	0.00198	0.00202	CcSEcCtD
Mepivacaine—Paraesthesia—Epirubicin—ovarian cancer	0.00197	0.00201	CcSEcCtD
Mepivacaine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00196	0.002	CcSEcCtD
Mepivacaine—Somnolence—Epirubicin—ovarian cancer	0.00195	0.00199	CcSEcCtD
Mepivacaine—Nausea—Docetaxel—ovarian cancer	0.00193	0.00197	CcSEcCtD
Mepivacaine—Hypotension—Doxorubicin—ovarian cancer	0.0019	0.00193	CcSEcCtD
Mepivacaine—Paraesthesia—Doxorubicin—ovarian cancer	0.00182	0.00186	CcSEcCtD
Mepivacaine—Somnolence—Doxorubicin—ovarian cancer	0.0018	0.00184	CcSEcCtD
Mepivacaine—Urticaria—Epirubicin—ovarian cancer	0.00174	0.00177	CcSEcCtD
Mepivacaine—Body temperature increased—Epirubicin—ovarian cancer	0.00173	0.00177	CcSEcCtD
Mepivacaine—Hypersensitivity—Epirubicin—ovarian cancer	0.00162	0.00165	CcSEcCtD
Mepivacaine—Urticaria—Doxorubicin—ovarian cancer	0.00161	0.00164	CcSEcCtD
Mepivacaine—Body temperature increased—Doxorubicin—ovarian cancer	0.0016	0.00163	CcSEcCtD
Mepivacaine—Asthenia—Epirubicin—ovarian cancer	0.00157	0.0016	CcSEcCtD
Mepivacaine—Pruritus—Epirubicin—ovarian cancer	0.00155	0.00158	CcSEcCtD
Mepivacaine—Hypersensitivity—Doxorubicin—ovarian cancer	0.0015	0.00152	CcSEcCtD
Mepivacaine—Asthenia—Doxorubicin—ovarian cancer	0.00146	0.00148	CcSEcCtD
Mepivacaine—Dizziness—Epirubicin—ovarian cancer	0.00145	0.00148	CcSEcCtD
Mepivacaine—Pruritus—Doxorubicin—ovarian cancer	0.00144	0.00146	CcSEcCtD
Mepivacaine—Vomiting—Epirubicin—ovarian cancer	0.0014	0.00142	CcSEcCtD
Mepivacaine—Headache—Epirubicin—ovarian cancer	0.00137	0.0014	CcSEcCtD
Mepivacaine—Dizziness—Doxorubicin—ovarian cancer	0.00134	0.00137	CcSEcCtD
Mepivacaine—Nausea—Epirubicin—ovarian cancer	0.0013	0.00133	CcSEcCtD
Mepivacaine—Vomiting—Doxorubicin—ovarian cancer	0.00129	0.00131	CcSEcCtD
Mepivacaine—Headache—Doxorubicin—ovarian cancer	0.00127	0.00129	CcSEcCtD
Mepivacaine—Nausea—Doxorubicin—ovarian cancer	0.00121	0.00123	CcSEcCtD
